Cell Signaling Technology

Annexin A1 (D5V2T) Rabbit Monoclonal Antibody (BSA and Azide Free)

#30797 · western blot · $865

64
Evidence Score · Well-Established
Used by 141 independent labs across 153 papers. How we score this →
29
Citing papers
1.7k
Combined citations
Supplier page Find this product

Research areas

Alzheimer's disease research and treatments10Ubiquitin and proteasome pathways5Cancer-related Molecular Pathways4Neuroscience and Neuropharmacology Research4Cancer, Hypoxia, and Metabolism3Amyloidosis: Diagnosis, Treatment, Outcomes2Microbial metabolism and enzyme function2Cholinesterase and Neurodegenerative Diseases2

Papers citing this product

1
SOX2 is a dose-dependent regulator of retinal neural progenitor competence
Genes & Development·2006·561 cit.·DOI
2
An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
EMBO Molecular Medicine·2015·180 cit.·DOI
3
Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice
Biochemical Journal·2011·119 cit.·DOI
4
LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
Oncogene·2018·86 cit.·DOI
5
Distinct <i>in vivo</i> roles of secreted <scp>APP</scp> ectodomain variants <scp>APP</scp> sα and <scp>APP</scp> sβ in regulation of spine density, synaptic plasticity, and cognition
The EMBO Journal·2018·84 cit.·DOI
6
Estrogen-Mediated Regulation of p38 Mitogen-Activated Protein Kinase in Human Endometrium
The Journal of Clinical Endocrinology & Metabolism·2006·77 cit.·DOI
7
Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion
Journal of Neuroscience·2018·76 cit.·DOI
8
Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
Oncotarget·2018·69 cit.·DOI
9
Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase
Nature Communications·2013·55 cit.·DOI
10
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures
Journal for ImmunoTherapy of Cancer·2023·52 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
Annexin A1 AntibodyRabbitCell Signaling Technology64$314100
Annexin A1 (D5V2T) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology64$161,38419
Annexin A1 (D5V2T) Rabbit Monoclonal Antibody (PE Conjugate)RabbitCell Signaling Technology64$4654

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.